Cargando…
Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling
The bulk of familial breast cancer risk (∼70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome...
Autores principales: | Hilbers, Florentine S., Meijers, Caro M., Laros, Jeroen F. J., van Galen, Michiel, Hoogerbrugge, Nicoline, Vasen, Hans F. A., Nederlof, Petra M., Wijnen, Juul T., van Asperen, Christi J., Devilee, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561352/ https://www.ncbi.nlm.nih.gov/pubmed/23383274 http://dx.doi.org/10.1371/journal.pone.0055734 |
Ejemplares similares
-
aCGH-MAS: Analysis of aCGH by means of Multiagent System
por: De Paz, Juan F., et al.
Publicado: (2015) -
SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets
por: Lai, Carmen, et al.
Publicado: (2007) -
Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer
por: Hilbers, Florentine S., et al.
Publicado: (2020) -
Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
por: Holstege, Henne, et al.
Publicado: (2010) -
A multiplex PCR predictor for aCGH success of FFPE samples
por: van Beers, E H, et al.
Publicado: (2006)